WSMD2017 - Workshop on Schizophrenia and other Mental Disorders
Largo Bruno Pontecorvo, 3
Alberto Del Guerra
The aims of the Workshop on Schizophrenia and other mental disorders are to showcase the latest developments in EU-funded research in the field of brain imaging tools for mental disorders (diagnosis, monitoring and management) and to explore the research and innovation challenges to be addressed for advancing the field.
The Workshop will bring together the investigators involved in collaborative research projects funded by the EU through the Seventh Framework Programme (call HEALTH.2013.2.2.1-2: Development of effective imaging tools for diagnosis, monitoring and management of mental disorders) and the "Innovative Medicines Initiative". EU-funded projects on neurodegenerative diseases will also be represented to gain a broader view on the state-of-play of brain imaging tools for brain disorders.
Participants will present their results and have the possibility to interact and discuss their findings. It will also be an opportunity to explore how to coordinate their efforts and capitalise on their results.
The Workshop will conclude with a roundtable with selected panellists who will discuss how to best address challenges and needs identified by the participants during the event.
The Workshop is organised in collaboration with the European Commission Directorate General for Research and Innovation and the EU Joint Undertaking Initiative "Innovative Medicines Initiative" and is under the patronage of the European Psychiatric Association.
PSYSCAN: Translating neuroimaging findings from research into clinical practice
(King's College London)
TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia
Alberto Del Guerra
MINDVIEW: Multimodal Imaging of Neurological Disorders
(University of Valencia)
The view of the Pharmaceutical European Industry in Neuroscience
(Johnson & Johnson)
Status of the FP7 and Horizon 2020 funded projects on mental disorders (continued)
(Gregorio Marañón Hospital), Paolo Brambilla
(University of Milano)
IMAGEMEND: IMAging GEnetics for MENtal Disorders
(University of Bari)
BRAINTRAIN: Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders
(Cardiff University (UK))
BIOCOG: Biomarker Development for Postoperative Cognitive Impairment in the Elderly
Georg Winterer Charité
(Universitätsmedizin Berlin (Germany))
METSY: Neuroimaging platform for characterisation of metabolic co-morbidities in psychotic disorders
(University of Turku (Finland))
LIFEBRAIN: Healthy minds from 0-100 years: Optimising the use of European brain imaging cohorts
Klaus P. Ebmeier
(University of Oxford (UK))
The IMI contribution in Brain studies
(University of Milano (Italy)), Karsten Heekeren
(University of Zürich (Switzerland))
The IMI consortium and the IMI funded projects in Central Nervous System (CNS)
RADAR CNS: Use of Wearable Devices and Mobile Technology to Understand the Course of Brain Diseases
(Janssen Pharmaceuticals (Belgium))
PRISM: Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer’s Disease, Schizophrenia, and Mayor Depression